NEW YORK (GenomeWeb) – Molecular diagnostics firm Nanosphere reported after the close of the market today record preliminary revenues for the fourth quarter and full-year 2015.

The company said revenue rose 48 percent year over year in Q4 to $6.8 million from $4.6 million in Q4 2014. Nanosphere also reported preliminary full-year 2015 revenues of $21 million, a 47 percent increase over $14.3 million in 2014 and above its 2015 revenue guidance of $18 million to $20 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.